Fundz

Mezzion Pharmaceuticals Appoints Ridwan Shabsigh as President and COO

PRIVATEJan 06, 2026

Position

Chief Operating Officer

Company

Mezzion Pharma

Ridwan Shabsigh
ridwan.shabsigh@mezzion.com
Fort LeeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Mezzion Pharmaceuticals has appointed Ridwan Shabsigh, MD, FACS to the newly created role of President and Chief Operating Officer. His extensive experience will support the advancement of the company's clinical trial and prepare for potential commercialization.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Mezzion Pharma, and when

A new leader at Mezzion Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Mezzion Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mezzion Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mezzion Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mezzion Pharma

Location

Fort Lee, New Jersey, United States

About

Mezzion Pharmaceuticals, Inc., a U.S.-based subsidiary of Mezzion Pharma Co., Ltd. (KOSDAQ: 140410), is a late-stage biopharmaceutical company focused on developing therapies for rare and underserved diseases. Mezzion is advancing JURVIGO® (udenafil) through a global Phase 3 clinical program as a potential first-in-class therapy for patients with single ventricle congenital heart disease and Fontan physiology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mezzion Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

John
Likely contact at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mezzion Pharma's next move

Learn about Strategic plan

Mezzion Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.